You are here

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

Review
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells

Authors

  • Sainiteesh Maddineni Department of Otolaryngology – Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA PubMed articlesGoogle scholar articles
  • John L Silberstein Program in Immunology, Stanford University School of Medicine, Palo Alto, California, USADepartment of Bioengineering, Stanford University, Palo Alto, California, USA PubMed articlesGoogle scholar articles
  • John B Sunwoo Department of Otolaryngology – Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor John B Sunwoo; sunwoo{at}stanford.edu
View Full Text

Citation

Maddineni S, Silberstein JL, Sunwoo JB
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Journal for ImmunoTherapy of Cancer 2022;10:e004693. doi: 10.1136/jitc-2022-004693

Publication history

  • Accepted April 23, 2022
  • First published May 17, 2022.
Online issue publication 
January 25, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.